Members of the U.S. Army Oregon National Guard have been re-deployed to assist OHSU and other hospitals statewide to help manage the COVID-19 surge and address staffing shortages.

A report on the FDA granting breakthrough device designation to a new test for a protein that may be an indicator of Alzheimer’s disease with Lewy bodies; an analysis was conducted at OHSU.

OHSU continues on the path toward becoming an anti-racist institution that both reflects and serves Oregon’s diverse population, the university’s board of directors heard during its quarterly meeting Jan. 28.

Luciole Pharmaceuticals and OHSU announce a research agreement to accelerate treatment discovery for neurodegenerative and other diseases of aging.

Michael Heinrich, M.D., presents results from a phase III clinical study at the annual American Society of Clinical Oncology Gastrointestinal Conference: “It is important to provide the detailed results of this study to the oncology community to help treating physicians make well-informed decisions on the best treatment options for their patients with advanced GIST."

New research led by Dawn Nolt, M.D., identifies risk for infectious diseases associated with emerging alternative peripartum and neonatal practices.

Story about opposition to the OHA's permanent indoor masking policy, Mary Tanski, M.D., speaks to the benefits of wearing masks to prevent COVID-19 spread, infection

Debbie Lamberger, M.P.A., describes OHSU's partnership with OHA to expand local COVID-19 testing and vaccination options, including a new community testing site on OHSU’s Marquam Hill campus and a new community vaccination site on OHSU’s South Waterfront campus.

KPOV-Radio in Central Point talks to Dawn Nolt, M.D., about the omicron surge and value of getting vaccinated.

The Jan. 20 COVID-19 forecast by Peter Graven, Ph.D., shows a slight reduction in COVID-19 impacts on Oregon hospitals: The Associated Press article picked up by dozens of outlets nationwide.